Dina Jiesisibieke | Reproductive Health | Best Researcher Award

Posted on by Pencis

Ms. Dina Jiesisibieke | Reproductive Health | Best Researcher Award

Peking University Third Hospital | China

Author Profile

Scopus

Google Scholar

📌 DINA JIESISIBIEKE, M.D. CANDIDATE

🏥 CLINICAL MEDICINE AT PEKING UNIVERSITY THIRD HOSPITAL Peking University

🎓 EARLY ACADEMIC PURSUITS

Dina Jiesisibieke embarked on her medical journey at Peking University Third Hospital, where she has been pursuing a Doctor of Medicine (M.D.) degree since 2019. With an impressive GPA of 3.7/4.0, she has consistently demonstrated academic excellence and dedication to the field of clinical medicine. Her early academic years were marked by outstanding achievements, securing multiple scholarships and honors for her exceptional performance.

🏆 PROFESSIONAL ENDEAVORS

Beyond her academic pursuits, Dina has actively engaged in research and international exchange programs. In 2023, she participated in an exchange program at Mahidol University, where she gained hands-on experience in plastic surgery. This international exposure has broadened her clinical expertise and provided her with a global perspective on medical practices.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON REPRODUCTIVE HEALTH

Dina's research primarily focuses on reproductive medicine, specifically evaluating reproductive outcomes of conventional in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI). Her work was recognized at the prestigious American Society for Reproductive Medicine (ASRM) conference in 2023, where she submitted a research abstract detailing her cohort study on reproductive outcomes.

🌍 IMPACT AND INFLUENCE

Dina's contributions extend beyond academic excellence, as she actively participates in scholarly discourse and medical research. Her involvement in clinical studies and international exchange programs positions her as an emerging leader in the medical field. Through her dedication to medical research and clinical training, she continues to inspire and set a benchmark for aspiring medical professionals.

📚 ACADEMIC CITATIONS

Her research has been recognized at a high level, with a conference abstract submitted to the American Society for Reproductive Medicine. This recognition highlights her growing influence in reproductive medicine and her commitment to contributing valuable insights to the medical community.

🏅 SCHOLARSHIPS AND AWARDS

Dina has been the recipient of numerous prestigious scholarships and awards, recognizing her academic excellence and dedication:

  • Merit Student of Peking University
  • Peking University Southwest Associated University Guan Yanhui Medical Education Scholarship (2019-2021)
  • Model Student of Academic Records of Peking University (2020-2024)
  • Peking University Weicai Pharmaceutical Scholarship (2021-2022)

🌟 LEGACY AND FUTURE CONTRIBUTIONS

As an aspiring physician, Dina Jiesisibieke is committed to advancing the field of clinical medicine and reproductive health. Her contributions to research, combined with her strong academic foundation and clinical experience, set the stage for a promising career in medicine. With continued dedication, she is poised to make a lasting impact in the field of reproductive medicine and beyond.

📑NOTABLE PUBLICATIONS 

"Prevalence of eye and adnexal disorders among elderly inmates in Taiwan prisons" 

  • Authors: C., Tsai, Chingyao , Z.L., Jiesisibieke, Zhu Liduzi , P., Tao, Ping , C., Chien, Chingwen , T., Tung, Taohsin
  • Journal: BMC Public Health
  • Year: 2024

Ying Wang | Chromosomal Abnormalities | Best Researcher Award

Posted on by Pencis

Dr. Ying Wang | Chromosomal Abnormalities | Best Researcher Award 

Tongji medical college of huazhong university of science and technology | China

Author Profile

Scopus

【YING WANG: A DEDICATED HEMATOLOGY RESEARCHER】

🎓 EARLY ACADEMIC PURSUITS

Ying Wang’s passion for medicine began at a young age, inspiring her to pursue an extensive medical education. She completed eight years of rigorous training, which included five years of clinical medical study followed by three years specializing in hematology. During this time, she developed a strong interest in laboratory science and hematology technology. Her academic journey allowed her to master fundamental hematological knowledge and acquire essential experimental skills such as polymerase chain reaction (PCR), cell culture, and morphology. This foundation led her to continue her professional journey in the hematology laboratory upon graduation.

💼 PROFESSIONAL ENDEAVORS

Since 2008, Ying Wang has been working in the Hematology Laboratory of Tongji Hospital at Tongji Medical College, Huazhong University of Science and Technology. Her career began with a primary focus on cell morphology, which is the cornerstone of hematopathology. Over three years, she gained an in-depth understanding of the characteristics of different hematological testing methods, including morphology, immunology, cytogenetics, and molecular biology.

For the past seven years, her work has been centered on cytogenetics, particularly in chromosomal analysis and fluorescence in situ hybridization (FISH). Through dedicated training and hands-on practice, she has mastered G-banding chromosomal analysis and developed expertise in applying FISH techniques to malignant blood diseases.

Currently, she leads the Cytogenetics Group, overseeing four team members and ensuring the efficiency and accuracy of daily operations. Under her leadership, her team has successfully established cytogenetic analysis for blood diseases and has processed a significant volume of patient samples. Her contributions to the field are reflected in her authorship of two published research papers.

📝 CONTRIBUTIONS AND RESEARCH FOCUS ON CHROMOSOMAL ABNORMALITIES

Ying Wang’s research focuses on cytogenetic analysis in hematology, particularly in the chromosomal abnormalities associated with blood diseases. Her expertise in G-banding chromosomal analysis and FISH techniques has significantly enhanced diagnostic and prognostic capabilities in hematopathology. She has contributed extensively to the establishment and optimization of cytogenetic methodologies in her laboratory, leading to improved patient diagnoses and treatment strategies.

Despite the labor-intensive nature of cytogenetic analysis, she remains deeply passionate about her work. Knowing that her contributions provide crucial diagnostic and prognostic data to clinicians, she continues to dedicate herself to advancing the field of hematology.

🌟 IMPACT AND INFLUENCE

Ying Wang’s work has had a profound impact on the field of hematology, particularly in China. By pioneering cytogenetic analysis for blood diseases in her laboratory, she has played a critical role in improving diagnostic precision. Her leadership in the Cytogenetics Group has enabled her team to process a high volume of patient samples, ensuring timely and accurate results that guide treatment decisions.

Her research contributions have also influenced the broader scientific community through her publications. Additionally, her involvement as a member of the Hubei Medical Biology and Immunology Society demonstrates her commitment to professional collaboration and knowledge exchange within the field.

📊 ACADEMIC CITATIONS

Ying Wang has authored two peer-reviewed research papers focusing on cytogenetics and blood disease analysis. These publications have contributed to the scientific community’s understanding of chromosomal abnormalities in hematology. Her work continues to be cited by researchers working on similar topics, further solidifying her influence in the field.

💪 LEGACY AND FUTURE CONTRIBUTIONS

As she advances in her career, Ying Wang remains committed to furthering her expertise in hematology and cytogenetics. She acknowledges the limitations of her current knowledge and continuously seeks to expand her skills through further studies and international collaborations. She aspires to stay at the forefront of hematological advancements by engaging with leading laboratories worldwide.

Upon completing her further studies, she aims to implement cutting-edge techniques in her laboratory, thereby enhancing the quality and scope of cytogenetic analysis available to patients in China. Her long-term vision is to contribute to the continued evolution of hematology research and to provide even more precise and valuable diagnostic information for improved patient outcomes.

👨‍🎓 POSITIONS AND HONORS

  • 2008 – Present: Hematology Laboratory, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology (Specialized in Morphology and Cytogenetics).
  • 2017 – Present: Member, Hubei Medical Biology and Immunology Society, China.

📑NOTABLE PUBLICATIONS

"Increased Epstein‒Barr virus reactivation following prophylaxis for cytomegalovirus infection after haploidentical haematopoietic stem cell transplantation" 

  • Authors: X., Kong, Xin , Z., Xu, Ziyi , Y., Wu, Yanjun , Y., Zhao, Ye , F., Chen, Feng
  • Journal: Journal of Hematology and Oncology
  • Year: 2024

" Reduced-dose chemotherapy and blinatumomab as induction treatment for newly diagnosed Ph-negative B-cell precursor acute lymphoblastic leukemia: a phase 2 trial " 

  • Authors: J., Lu, Jing , H., Qiu, Huiying , Y., Wang, Ying , Y., Zhu, Yu , S., Chen, Suning
  • Journal: Journal of Hematology and Oncology
  • Year: 2024

"CD19 CAR T-cell therapy in relapsed TCF3-HLF-positive B-cell acute lymphoblastic leukemia" 

  • Authors: Y., Yao, Yao , J., Zhou, Jin , Y., Li, Yanting , D.P., Wu, De Pei , Y., Wang, Ying
  • Journal: Annals of Hematology
  • Year: 2024

"Risk factors for in-hospital mortality in recipients of allogeneic hematopoietic stem cell transplantation with acute respiratory distress syndrome: a retrospective study based on the 2023 new definition of acute respiratory distress syndrome " 

  • Authors: S., Guo, Shiqi , D., Xie, Dan , Y., Gao, Ye , Y., Wang, Ying , Q., Guo, Qiang
  • Journal: BMC Pulmonary Medicine
  • Year: 2024

"A phase II study of belumosudil for chronic graft-versus-host disease in patients who failed at least one line of systemic therapy in China " 

  • Authors: Y., Wang, Ying , D.P., Wu, De Pei , X., Zhang, Xiang , Y., Wang, Yu , Y., Zhang, Ying
  • Journal: BMC Medicine
  • Year: 2024

Pinelopi Petropoulou | Diabetes | Best Researcher Award

Posted on by Pencis

Dr. Pinelopi Petropoulou | Diabetes | Best Researcher Award

University of West Attica | Greece

Author Profile

Scopus

Orcid ID

📚 DR. PINELOPI PETROPOULOU: A MULTIFACETED EXPERT IN DENTISTRY AND PUBLIC HEALTH

📖 EARLY ACADEMIC PURSUITS

Dr. Pinelopi Petropoulou was born and resides in Athens, Greece. She pursued her academic journey in Dentistry at the Kapodistrian University of Athens. Demonstrating a commitment to specialized knowledge, she furthered her education with post-graduate studies in Periodontology and Prosthodontics at the English-speaking Witten/Herdecke University in Germany. Additionally, she completed advanced training in Implantology at the German Academy of Practice and Science (APW).

Her dedication to multidisciplinary expertise led her to become certified as a Laser Safety Officer by Aachen University and to receive certification from Demokritos for operating a Radiological Laboratory in Athens. Moreover, she is currently a Ph.D. candidate (PhDc) in Oncology Care at the University of West Attica and has pursued postgraduate studies in Planning and Implementing Gender Equality Policies at the Pedagogical Department of the University of the Aegean.

💼 PROFESSIONAL ENDEAVORS

Dr. Petropoulou operates a private dental clinic in Athens, where she applies her extensive expertise in periodontology, prosthodontics, and implantology. Her clinical practice is distinguished by a patient-centered approach and the integration of advanced medical technologies.

In addition to her clinical work, Dr. Petropoulou serves as a reviewer for several prestigious scientific journals, including the International Journal of Science, Technology and Society, Cureus, and Social Work: Review of Social Sciences. Her academic contributions extend to her role as an Academic Board Member for Global Open Share Publishing.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON DIABETES

Dr. Petropoulou's research interests are diverse, encompassing oncology care, public health, and advanced dental practices. She specializes in the treatment of oncological patients and has a particular focus on "Global Public Health and Environment." Her participation in numerous scientific conferences and her publications in peer-reviewed journals reflect her commitment to advancing knowledge in these fields.

Her work bridges the gap between dental health and broader public health concerns, contributing valuable insights into patient care and community health initiatives.

🌍 IMPACT AND INFLUENCE

Dr. Petropoulou's influence extends beyond her clinical and academic work into social advocacy and public service. As a member of Doctors of the World, she volunteered for the 2014-2015 primary schools dental problems registration and prevention campaign, earning recognition for her contributions.

She holds leadership roles in several prominent organizations, including:

  • Vice-President of the Women's Union of Greece (EGE) in Athens
  • International Relations Advisor for the Association of Greek Women Scientists (SEE)
  • Secretary of the Communication and Interconnection Department of the Hellenic Solid Waste Management Association (EEDSA)
  • Member of Women for Oncology Hellas
  • Member of the Amnesty International Board in Greece

Her active engagement in these organizations underscores her commitment to social responsibility, gender equality, and environmental sustainability.

📊 ACADEMIC CITATIONS

Dr. Petropoulou's scholarly work is recognized through her contributions to scientific literature and peer-reviewed journals. Her role as a reviewer further emphasizes her expertise and dedication to maintaining high academic standards. Her multidisciplinary research has informed best practices in both dentistry and public health.

🏆 LEGACY AND FUTURE CONTRIBUTIONS

Dr. Pinelopi Petropoulou's legacy lies in her integrative approach to dental medicine, oncology care, and public health advocacy. Her work exemplifies a commitment to interdisciplinary collaboration and the translation of research into meaningful societal impact.

Looking ahead, she aims to continue advancing oncology care, promoting gender equality in healthcare policy, and expanding her research in global public health. Through her clinical excellence, academic contributions, and social activism, Dr. Petropoulou continues to shape the future of healthcare and public welfare.

🌟 OTHER NOTABLE ACHIEVEMENTS

  • Multilingual: Fluent in English and French
  • Certified Laser Safety Officer and Radiological Laboratory Operator
  • Recognized volunteer service with Doctors of the World

Dr. Pinelopi Petropoulou's career is a testament to the power of combining clinical expertise, academic rigor, and social commitment to effect positive change on both local and global scales.

NOTABLE PUBLICATIONS📑

"Research of the air pollution connection with the presence and evοlution of chronic diseases" 

  • Authors: P., Petropoulou, Pinelopi , I., Kalemikerakis, Ioannis , O., Govina, Ourania
  • Journal: Archives of Hellenic Medicine
  • Year: 2025

Ehab Darwish | Host Genetics | Best Researcher Award

Posted on by Pencis

Dr. Ehab Darwish | Host Genetics | Best Researcher Award

Author Profile

Scopus

Orcid ID

Faculty of Medicine, King Faisal University | Saudi Arabia

Biography of Dr. Ehab Mohamed Ibrahim Darwish: A Pioneer in Tropical Medicine, Gastroenterology, and Infectious Diseases 🌍

EARLY ACADEMIC PURSUITS 🎓

Dr. Ehab Mohamed Ibrahim Darwish embarked on his medical journey at Zagazig University, Egypt, where he earned his M.B., B.Ch. in Medicine in 1999. Driven by a passion for advancing his expertise in health sciences, Dr. Darwish pursued a Master’s degree in Tropical Medicine in 2004, followed by a Doctorate in Tropical Medicine in 2009. These foundational years shaped his deep interest in infectious diseases, hepatology, and gastroenterology, setting the stage for a dedicated career in medicine and research.

PROFESSIONAL ENDEAVORS 🏥

Dr. Darwish has held prestigious academic positions, including his role as an Assistant Professor of Gastroenterology, Hepatology & Infectious Diseases at Zagazig University. In June 2015, he joined King Faisal University in Saudi Arabia, where he currently serves as an Assistant Professor in the Department of Internal Medicine at the College of Medicine. His international experience has enabled him to bring a wealth of knowledge to his students and to the broader medical community in Saudi Arabia.

CONTRIBUTIONS AND RESEARCH FOCUS ON HOST GENETICS 📊

Throughout his career, Dr. Darwish has actively contributed to research in infectious diseases, hepatology, and gastroenterology. He has published numerous studies, several of which appear in Scopus-indexed and Web of Science journals. His research often addresses genetic factors in infectious diseases, an area where he has made impactful discoveries that are critical to understanding disease susceptibility and treatment response. Dr. Darwish's research accomplishments include 17 completed projects and 3 ongoing research initiatives, marking him as a prolific contributor to medical science.

IMPACT AND INFLUENCE 🌟

With a Scopus H-index of 3 and 61 citations, Dr. Darwish’s work has been recognized for its contributions to the fields of tropical medicine and infectious diseases. His research has provided essential insights into the prevention and treatment of various gastrointestinal and liver-related illnesses. Through both his teaching and research, he has influenced medical students and peers alike, emphasizing the importance of scientific inquiry in clinical practice.

ACADEMIC CITATIONS 📈

Dr. Darwish’s publications include six research articles in SCI and Scopus-indexed journals, underscoring his commitment to producing high-quality, peer-reviewed research. His work is frequently cited, reflecting his influence in tropical medicine and internal medicine. His dedication to understanding the genetic basis of infectious diseases has added a valuable dimension to his research, enhancing its applicability in both clinical and research settings.

LEGACY AND FUTURE CONTRIBUTIONS 🌍

Looking forward, Dr. Darwish aims to expand his research on genetics in infectious diseases, with plans to contribute to advancements in personalized medicine. His legacy is marked by his commitment to bridging clinical practice with research, fostering a generation of medical professionals trained in both the practical and theoretical aspects of medicine. Through continued collaborations, publications, and mentorship, Dr. Darwish is set to make lasting contributions to the global medical community.

OTHER SIGNIFICANT TOPICS AND PROFESSIONAL HIGHLIGHTS 🏆

  • Areas of Research: Dr. Darwish’s expertise spans infectious diseases, hepatology, and gastroenterology, focusing on improving patient outcomes in these critical areas.
  • Completed and Ongoing Research Projects: With 17 completed and 3 ongoing projects, Dr. Darwish has maintained a productive and impactful research portfolio.
  • Professional Memberships and Collaborations: His involvement in professional networks and collaborations has strengthened his contributions and broadened the scope of his research.

NOTABLE PUBLICATIONS 📑

"Value of Serum miRNA-96-5p and miRNA-99a-5p as Diagnostic Biomarkers for Hepatocellular Carcinoma, " 

  • Authors: Gharib, A.F., , Eed, E.M., Khalifa, A.S., Darwiesh, E., Essa, A.,
  • Journal: International Journal of General Medicine
  • Year: 2022

"BAR Score Performance in Predicting Survival after Living Donor Liver Transplantation: A Single-Center Retrospective Study " 

  • Authors: Zakareya, T. , Taha, M. , Elzohry, H. ,Deif, M. , Abbasy, M.
  • Journal:  Canadian Journal of Gastroenterology and Hepatology
  • Year: 2022

"Role of interferon gamma in SARS-CoV-2-positive patients with parasitic infections " 

  • Authors: Abdel-Hamed, E.F. , Ibrahim, M.N. , Mostafa, N.E. , Al-Khoufi, E.A. , Hindawi, S.I.
  • Journal: Gut Pathogens
  • Year: 2021

"Endoscopic removal of foreign bodies from the upper gastrointestinal tract: 5-year experience" 

  • Authors: Emara, M.H. , Darwiesh, E.M. , Refaey, M.M. , Galal, S.M.
  • Journal: Clinical and Experimental Gastroenterology
  • Year: 2014

"Endoscopic injection of autologous blood versus diluted epinephrine for control of actively bleeding gastroduodenal ulcers: A randomized-controlled study" 

  • Authors: Emara, M.H. , Darwiesh, E.M. , Bihery, A.S. , Zaher, T.I.
  • Journal: European Journal of Gastroenterology and Hepatology
  • Year: 2014

Spyridon Theofilopoulos | Development Neurobiology | Best Researcher Award

Posted on by Pencis

Prof. Spyridon Theofilopoulos | Development Neurobiology | Best Researcher Award

Deree-The American College of Greece | Greece

AUTHOR PROFILE

Scopus

Orcid ID

Google Scholar

EARLY ACADEMIC PURSUITS

Spyridon Theofilopoulos embarked on his academic journey with a Bachelor of Science degree in Biochemistry from Imperial College of Science, Technology and Medicine, London, U.K. Following this, he pursued his passion for developmental neurobiology, obtaining his Ph.D. from the same institution. His doctoral research, supervised by Professor Henry F. Bradford, focused on neurotrophic factors in neurotransmitter phenotype determination and neuroprotection in the developing human and rat brain.

PROFESSIONAL ENDEAVORS

Dr. Theofilopoulos has held various academic positions internationally, demonstrating his expertise and commitment to the field. Noteworthy roles include his tenure as a Forskare (Senior Researcher/Assistant Professor) at the Karolinska Institute, Stockholm, Sweden, and as a Sêr Cymru II Rising Star fellow and Associate Professor at Swansea University Medical School, Swansea, U.K. Currently, he serves as a Professor and Instructor at the Biomedical Sciences Department of Deree-The American College of Greece, Athens, Greece.

CONTRIBUTIONS AND RESEARCH FOCUS ON DEVELOPMENT NEUROBIOLOGY

Dr. Theofilopoulos has made significant contributions to the field of developmental neurobiology, particularly in the areas of neuroprotection and neurotransmitter phenotype determination. His collaborative research with Teva Pharmaceuticals during his Ph.D. led to the development of Rasagiline, a novel compound for the treatment of Parkinson’s disease. Moreover, his work at Swansea University resulted in the establishment of the spin-off company CholesteniX Ltd, aiming to develop specific cholesterol metabolites for Amyotrophic Lateral Sclerosis therapy.

IMPACT AND INFLUENCE

Theofilopoulos's research has not only contributed to scientific advancements but has also garnered recognition and accolades. He has been invited as a speaker to numerous conferences and meetings, highlighting the impact of his work in the scientific community. Furthermore, his efforts were acknowledged with awards such as the "Outstanding Research and Innovation collaboration in Medicine, Health and Life Sciences" award in 2022.

ACADEMIC CITATIONS

Dr. Theofilopoulos's work has been cited extensively, indicating its relevance and impact in the scientific community. His publications have appeared in reputable journals, and he has served as a reviewer for various scientific publications, including Scientific Reports, eLife, and Frontiers in Cell and Developmental Biology.

LEGACY AND FUTURE CONTRIBUTIONS

Dr. Theofilopoulos's legacy lies in his dedication to advancing knowledge in developmental neurobiology and his commitment to mentoring the next generation of scientists. His research funding awards underscore the importance of his work and pave the way for future discoveries in the field. As he continues his academic journey, his contributions are expected to further shape the landscape of neuroscience research.

NOTABLE PUBLICATIONS

The Cerebrospinal Fluid Profile of Cholesterol Metabolites in Parkinson’s Disease and Their Association With Disease State and Clinical Features 2021(10)

Inhibition of 7α,26-dihydroxycholesterol biosynthesis promotes midbrain dopaminergic neuron development 2024

Mining for oxysterols in cyp7b1−/− mouse brain and plasma: Relevance to spastic paraplegia type 5 2019(13)

24(S),25-Epoxycholesterol and cholesterol 24S-hydroxylase (CYP46A1) overexpression promote midbrain dopaminergic neurogenesis in vivo 2019(24)

Additional pathways of sterol metabolism: Evidence from analysis of Cyp27a1−/− mouse brain and plasma 2019(29)

Xiaohu Ren | Metabolic disorders and their genetic basis | Best Researcher Award

Posted on by Pencis

Prof Dr. Xiaohu Ren | Metabolic disorders and their genetic basis | Best Researcher Award

Shenzhen Center for Disease Control and Prevention | China

Author Profile

Scopus

Orcid ID

EARLY ACADEMIC PURSUITS:

Dr. Xiaohu Ren commenced his academic journey with a Bachelor of Science in Biological Sciences from Shenzhen University (2005-2009), followed by a Master of Science in Biochemistry and Molecular Biology (2009-2012) from the same institution. Subsequently, he pursued a Ph.D. in Health Toxicology at Southern Medical University (2012-2015), where he laid the foundation for his research expertise in the field of toxicology.

PROFESSIONAL ENDEAVORS:

Since 2015, Dr. Ren has served as an Associate Chief Physician and Assistant Researcher at the Modern Toxicology Laboratory, Shenzhen Center for Disease Control and Prevention (CDC). Prior to this, he contributed as a Postdoctoral Researcher at the Shenzhen CDC from 2015 to 2017. These roles have provided him with ample opportunities to delve into the intricacies of environmental pollutants and occupational toxicants research.

CONTRIBUTIONS AND RESEARCH FOCUS ON METABOLIC DISORDERS AND THEIR GENETIC BASIS:

Dr. Ren's research endeavors have predominantly revolved around unraveling the molecular mechanisms underlying the damage inflicted on the human body by toxic substances. His expertise spans various analytical techniques, including proteomics, untargeted lipidomics, metabolomics, and cell phenotyping. Noteworthy among his contributions are the establishment of several toxicological testing and analysis methodologies, which have significantly advanced the field.

IMPACT AND INFLUENCE:

As an active member of numerous toxicological societies and committees in China, Dr. Ren has played a pivotal role in shaping the discourse surrounding toxicology research in the country. His work has garnered attention both nationally and internationally, contributing to the broader understanding of environmental health and toxicology.

ACADEMIC CITATIONS:

Dr. Ren's research findings have been cited extensively in the academic community, attesting to the significance and relevance of his contributions to the field. His publications have enriched the scientific literature on DNA repair pathways affected by environmental toxicants and carcinogenesis, shedding light on critical aspects of human health and disease.

LEGACY AND FUTURE CONTRIBUTIONS:

With a solid foundation established through years of academic pursuit and professional engagement, Dr. Xiaohu Ren continues to be a driving force in toxicology research. His legacy encompasses a body of work that has not only advanced scientific knowledge but also contributed to the development of practical solutions for mitigating the adverse effects of environmental pollutants. Moving forward, Dr. Ren remains committed to furthering his research agenda, with a focus on addressing emerging challenges in the field and making lasting contributions to public health and environmental well-being.

Notable Publications

Co-exposure to parabens and triclosan and associations with cognitive impairment in an elderly population from Shenzhen, China 2023(2)

Long term exposure of saxitoxin induced cognitive deficits and YAP1 cytoplasmic retention 2023(2)

The relative and interactive effects of urinary multiple metals exposure on hyperuricemia among urban elderly in China 2023(4)

Association between human herpesvirus 6 (HHV-6) and cognitive function in the elderly population in Shenzhen, China 2022(3)